NEW YORK (GenomeWeb News) – BG Medicine has tapped Paul Sohmer to be president, CEO, and a member of its board of directors, effective immediately, the company said this week.

Sohmer previously was CEO of several medical device and diagnostics companies, including Pathway Diagnostics, Viracor-IBT Laboratories, and Orthocon, and he was chairman, president, and CEO of TriPath Imaging before it was acquired by Becton Dickinson.

Early in his career, Sohmer also was CEO of Genetrix, a genetic testing lab that was acquired by Genzyme.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.